Importantly, the evidence discussed in the review suggests that the degree of β1-adrenoceptor selectivity may influence beta-blocker choice, particularly when pulmonary tolerability is a concern. Here are five key points for clinicians from this latest published paper. A key concern…
Samsung announced that its Galaxy Ring has received FDA clearance to monitor for signs of sleep apnea, a first for smart rings currently on the market. According to Samsung, the update Sleep Apnea feature is intended for users over the…
As November marks COPD Awareness Month, Florida physicians are sounding the alarm about chronic obstructive pulmonary disease, or COPD, a disease that affects more than one million Floridians, led to nearly 35,000 hospitalizations across the state in 2025 and remains one of…
Air pollution, especially PM 2.5 fine particulate matter in large cities, is becoming a challenge for the environment and public health. According to Mr. Le Hoai Nam, Deputy Director of the Department of Environment ( Ministry of Agriculture and Environment ), air pollution…
Provided by UMC Health System “These recognitions reflect UMC’s commitment to clinical excellence and the dedication of our physicians, nurses and care teams to deliver high-quality specialty care,” said Monica Beardemphl, Chief Experience Officer at UMC Health System. “We continually…
A 4-year-old boy in India had a cough with an odd, intermittent whistle. He otherwise felt fine. His parents mentioned one detail: before the coughing started, he had been playing with a toy whistle. An X-ray showed his left lung…
Presented by The Community Oncology Alliance Experts say no inhaler suits every patient with chronic obstructive pulmonary disease, and technique can fade within 30 days without retraining. There isn’t yet a perfect chronic obstructive pulmonary disease (COPD) inhaler, and even a…
Presented by The Community Oncology Alliance Experts say COPD care should aim for disease stability, with advanced therapy a routine next step, not a last resort, for patients who fall short. The GOLD report now gives clinicians a concrete goal…
Presented by The Community Oncology Alliance Imperial College London’s Jadwiga A. Wedzicha, MD, discusses anti-alarmin trial results in COPD and where biologics may fit in treatment. Epithelial alarmins play an important role in driving exacerbations of chronic obstructive pulmonary disease…
Looking to schedule an appointment? We now provide you with 24/7 electronic access to view your medical records, pay your bill and exchange secure messages with our staff. CRH at NexusPark2100 25th Street, Ste FColumbus, IN 47201 Monday, Tuesday, Thursday, Friday, 8am - 4:30pmWednesday, 8am - 3:30pm We are proud…
Asthma, COPD, sleep apnea, infections, and environmental lung risks.
An article joins this feed when it matches these terms. Each one is also a search of its own.